Oxybutynin Chloride
Product Images NDC 50090-4658

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904658)

Oxybutynin Chloride 10 mg extended-release tablets packaging label from A-S Medication Solutions. The label indicates a bottle containing 90 extended-release tablets, with storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture and heat. The product is identified by NDC 50090-4658-0.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 1)

Chemical structure of Oxybutynin Chloride showing its molecular arrangement with phenyl, cyclohexane, ester, alkyne, and diethylamino groups, along with the hydrochloride salt form.*

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

A line graph depicting mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours. The graph compares Oxybutynin Chloride ER Tablets 10 mg QD (once daily) and oxybutynin 5 mg TID (three times daily). Concentrations fluctuate over time, with error bars shown for each data point.*

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

A line graph showing the mean R-Oxybutynin plasma concentration (ng/mL) over a 24-hour period. The x-axis represents time in hours from 0 to 24, and the y-axis shows plasma concentration ranging from 0.0 to 2.0 ng/mL. Data points are plotted with error bars indicating variability at each time point.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

A horizontal error bar chart comparing Oxybutynin Chloride and placebo groups. The chart shows data points with error bars for both Oxybutynin Chloride and placebo, positioned on a scale ranging approximately from -40 to 40.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 5)

A horizontal error bar chart comparing data points labeled Oxybutynin Chloride and oxybutynin, each with corresponding error bars extending along the x-axis from approximately -40 to 40, centered near -20. The chart appears to visually represent statistical data related to these substances without additional axis labels or titles.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 6)

A horizontal error bar chart comparing Oxybutynin Chloride and oxybutynin, showing data points with negative values ranging approximately from -20 to -10. The x-axis ranges from -40 to 40, with labeled intervals every 20 units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.